51 related articles for article (PubMed ID: 3722413)
41. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
42. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
43. Apoptotic Janus-faced mycotoxins against thoracal and breast metastases.
Banfalvi G
Apoptosis; 2023 Jun; 28(5-6):754-768. PubMed ID: 37055605
[TBL] [Abstract][Full Text] [Related]
44. The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer.
Kay C; Martinez-Perez C; Dixon JM; Turnbull AK
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888087
[TBL] [Abstract][Full Text] [Related]
45. Natural history of breast cancer.
Pontén J
Acta Oncol; 1990; 29(3):325-9. PubMed ID: 2194532
[TBL] [Abstract][Full Text] [Related]
46. Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood.
Wall I; Boulat V; Shah A; Blenman KRM; Wu Y; Alberts E; Calado DP; Salgado R; Grigoriadis A
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139665
[TBL] [Abstract][Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
